M. Khazaei

发表

Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury

M. Fehlings, M. Shoichet, Satoshi Nori, 2018, Stem cell reports.

The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges

M. Fehlings, M. Khazaei, A. M. Siddiqui, 2014, Journal of clinical medicine.

Examining the fundamental biology of a novel population of directly reprogrammed human neural precursor cells

Cécile Boscher, M. Fehlings, Oana Mihai, 2019, Stem Cell Research & Therapy.

Exogenous Neural Precursor Cell Transplantation Results in Structural and Functional Recovery in a Hypoxic-Ischemic Hemiplegic Mouse Model

Ravi S. Menon, D. van der Kooy, R. Menon, 2018, eNeuro.

Research applications of induced pluripotent stem cells for treatment and modeling of spinal cord injury

M. Fehlings, M. Khazaei, W. B. McIntyre, 2022, Novel Concepts in iPSC Disease Modeling.

Neural Progenitor Cells Expressing Herpes Simplex Virus-Thymidine Kinase for Ablation Have Differential Chemosensitivity to Brivudine and Ganciclovir

M. Fehlings, C. Rodgers, Christopher S Ahuja, 2021, Frontiers in Cellular Neuroscience.

Administration of C5a receptor antagonist improves the efficacy of human iPSCs-derived NS/PC transplantation in the acute phase of spinal cord injury.

H. Okano, M. Fehlings, J. Kohyama, 2020, Journal of neurotrauma.

Generation of Definitive Neural Progenitor Cells from Human Pluripotent Stem Cells for Transplantation into Spinal Cord Injury.

M. Fehlings, C. Rodgers, Christopher S Ahuja, 2019, Methods in molecular biology.

Cell–Cell Contact Mediates Gene Expression and Fate Choice of Human Neural Stem/Progenitor Cells

M. Fehlings, Y. Riazalhosseini, Mehran Karimzadeh, 2022, Cells.

Making Neurons from Human Stem Cells

M. Fehlings, Christopher S Ahuja, M. Khazaei, 2018, Front. Young Minds..

Translating mechanisms of neuroprotection, regeneration, and repair to treatment of spinal cord injury.

M. Fehlings, M. Khazaei, A. Siddiqui, 2015, Progress in brain research.

The Protein Kinase Inhibitor Midostaurin Improves Functional Neurological Recovery and Attenuates Inflammatory Changes Following Traumatic Cervical Spinal Cord Injury

M. Fehlings, James Hong, Jian Wang, 2021, Biomolecules.

Induced Pluripotent Stem Cells for Traumatic Spinal Cord Injury

M. Fehlings, Christopher S Ahuja, M. Khazaei, 2017, Front. Cell Dev. Biol..

The leading edge: Emerging neuroprotective and neuroregenerative cell‐based therapies for spinal cord injury

D. van der Kooy, M. Fehlings, Charles Tator, 2020, Stem cells translational medicine.

GDNF rescues the fate of neural progenitor grafts by attenuating Notch signals in the injured spinal cord in rodents

M. Fehlings, N. Nagoshi, S. Shibata, 2020, Science Translational Medicine.

Severe-combined immunodeficient rats can be used to generate a model of perinatal hypoxic-ischemic brain injury to facilitate studies of engrafted human neural stem cells

M. Fehlings, S. Altamentova, James Hong, 2018, PloS one.

Collapsin Response Mediator Protein 4 Regulates Growth Cone Dynamics through the Actin and Microtubule Cytoskeleton*

J. Cloutier, A. Fournier, G. Brouhard, 2014, The Journal of Biological Chemistry.

Human Spinal Oligodendrogenic Neural Progenitor Cells Promote Functional Recovery After Spinal Cord Injury by Axonal Remyelination and Tissue Sparing

M. Fehlings, N. Nagoshi, Satoshi Nori, 2018, Stem cells translational medicine.

In Vivo Neocortical [K]o Modulation by Targeted Stimulation of Astrocytes

Paolo Bazzigaluppi, P. Carlen, B. Stefanovic, 2021, International journal of molecular sciences.

Regenerative replacement of neural cells for treatment of spinal cord injury

M. Fehlings, M. Khazaei, W. B. McIntyre, 2021, Expert opinion on biological therapy.

Generation of Oligodendrogenic Spinal Neural Progenitor Cells From Human Induced Pluripotent Stem Cells.

M. Fehlings, Christopher S Ahuja, M. Khazaei, 2017, Current protocols in stem cell biology.

Collapsin Response Mediator Protein 4 (CRMP4) Facilitates Wallerian Degeneration and Axon Regeneration following Sciatic Nerve Injury

A. Fournier, C. Deppmann, N. Unsain, 2020, eNeuro.

Novel innovations in cell and gene therapies for spinal cord injury

A. Toossi, M. Fehlings, James Hong, 2020, F1000Research.

Examining the fundamental biology of a novel population of directly reprogrammed human neural precursor cells

Cécile Boscher, M. Fehlings, C. Morshead, 2019, Stem Cell Research & Therapy.

Promoting the Differentiation of Neural Progenitor Cells into Oligodendrocytes through the Induction of Olig2 Expression: A Transcriptomic Study Using RNA-seq Analysis

M. Fehlings, M. Khazaei, Katarzyna Pieczonka, 2023, Cells.

Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model.

M. Fehlings, N. Nagoshi, S. Shibata, 2023, Stem Cells Translational Medicine.

How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?

M. Fehlings, M. Khazaei, Raymond Wong, 2023, Expert opinion on biological therapy.

Translating mechanisms of neuroprotection, regeneration, and repair to treatment of spinal cord injury.

M. Fehlings, M. Khazaei, Ahad M. Siddiqui, 2015, Progress in brain research.

Administration of C5a receptor antagonist improves the efficacy of human iPSCs-derived NS/PC transplantation in the acute phase of spinal cord injury.

M. Fehlings, N. Nagoshi, Satoshi Nori, 2022, Journal of neurotrauma.